JPS56138115A - Suppository containing acidic amino acid or derivative thereof - Google Patents
Suppository containing acidic amino acid or derivative thereofInfo
- Publication number
- JPS56138115A JPS56138115A JP4036980A JP4036980A JPS56138115A JP S56138115 A JPS56138115 A JP S56138115A JP 4036980 A JP4036980 A JP 4036980A JP 4036980 A JP4036980 A JP 4036980A JP S56138115 A JPS56138115 A JP S56138115A
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- amino acid
- acidic amino
- suppository
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002378 acidificating effect Effects 0.000 title abstract 4
- 150000001413 amino acids Chemical class 0.000 title abstract 4
- 239000000829 suppository Substances 0.000 title abstract 4
- 150000001412 amines Chemical class 0.000 title 1
- 229940024606 amino acid Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000055006 Calcitonin Human genes 0.000 abstract 1
- 108060001064 Calcitonin Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
- 229960004015 calcitonin Drugs 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- -1 heparin Chemical compound 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000013923 monosodium glutamate Nutrition 0.000 abstract 1
- 239000000813 peptide hormone Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229940073490 sodium glutamate Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4036980A JPS56138115A (en) | 1980-03-31 | 1980-03-31 | Suppository containing acidic amino acid or derivative thereof |
EP81102336A EP0037943B1 (en) | 1980-03-31 | 1981-03-27 | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
DE8181102336T DE3171774D1 (en) | 1980-03-31 | 1981-03-27 | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
US06/249,462 US4434159A (en) | 1980-03-31 | 1981-03-31 | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4036980A JPS56138115A (en) | 1980-03-31 | 1980-03-31 | Suppository containing acidic amino acid or derivative thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56138115A true JPS56138115A (en) | 1981-10-28 |
JPH0242809B2 JPH0242809B2 (enrdf_load_stackoverflow) | 1990-09-26 |
Family
ID=12578721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4036980A Granted JPS56138115A (en) | 1980-03-31 | 1980-03-31 | Suppository containing acidic amino acid or derivative thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56138115A (enrdf_load_stackoverflow) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01279839A (ja) * | 1988-04-30 | 1989-11-10 | Nitto Denko Corp | 水溶性生理活性蛋白質製剤 |
AT396424B (de) * | 1987-09-15 | 1993-09-27 | Sandoz Ag | Calcitoninsuppositorien |
JP2020002081A (ja) * | 2018-06-29 | 2020-01-09 | 小林製薬株式会社 | ゼラチン含有組成物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55153712A (en) * | 1979-05-18 | 1980-11-29 | Kao Corp | Insulin pharmaceutical preparation and its production |
JPS56127338A (en) * | 1980-03-10 | 1981-10-06 | Morishita Seiyaku Kk | Basic amino acid salt of diclofenac and suppository containing the same |
-
1980
- 1980-03-31 JP JP4036980A patent/JPS56138115A/ja active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55153712A (en) * | 1979-05-18 | 1980-11-29 | Kao Corp | Insulin pharmaceutical preparation and its production |
JPS56127338A (en) * | 1980-03-10 | 1981-10-06 | Morishita Seiyaku Kk | Basic amino acid salt of diclofenac and suppository containing the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT396424B (de) * | 1987-09-15 | 1993-09-27 | Sandoz Ag | Calcitoninsuppositorien |
JPH01279839A (ja) * | 1988-04-30 | 1989-11-10 | Nitto Denko Corp | 水溶性生理活性蛋白質製剤 |
JP2020002081A (ja) * | 2018-06-29 | 2020-01-09 | 小林製薬株式会社 | ゼラチン含有組成物 |
Also Published As
Publication number | Publication date |
---|---|
JPH0242809B2 (enrdf_load_stackoverflow) | 1990-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS56100714A (en) | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane | |
IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
AU4722785A (en) | Initiating reperfusion treatment when heart attack symptoms are present | |
ES2117642T3 (es) | Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles. | |
DK642587A (da) | Insulinpraeparat | |
DE3271829D1 (en) | An allergen dry powder composition and process for its preparation | |
PL345959A1 (en) | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | |
JPS56104815A (en) | Remedy for peripheral orthostatic hypotension | |
PT78628B (en) | Pharmaceutical composition with reduced toxicity | |
JPS56138111A (en) | Suppository containing unsaturated fatty acid or salt thereof | |
JPS5551020A (en) | Remedy for rheumatism | |
JPS56138110A (en) | Suppository containing citric acid or salt thereof | |
JPS56138115A (en) | Suppository containing acidic amino acid or derivative thereof | |
JPS56138112A (en) | Suppository containing ascorbic acid or sodium ascorbate | |
ES8301631A1 (es) | Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar. | |
JPS57128635A (en) | Pharmaceutical preparation of gamma-globulin for venoclysis | |
JPS56122310A (en) | Suppository | |
JPS57169425A (en) | Composition and method for preventing adsorption of secretin | |
JPS57126422A (en) | Stabilizing method of lysozyme pharmaceutical | |
Flournoy et al. | Relationship of serum gentamicin levels and methylprednisolone sodium succinate treatment in baboons challenged with Escherichia coli LD100 | |
JPS55122721A (en) | Antidiabetic agent | |
JPS5569510A (en) | Carcinostatic agent | |
RU96122371A (ru) | Способ лечения эндогенных и послеоперационных увеитов | |
JPS57163317A (en) | Stabilizing agent for peptide hormone | |
JPS5341418A (en) | Preparation of antibiotic preparations of aminoglycoside series suitable for rectal administration |